Paper14647405
CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers.
Fukuda T and 11 others. Pharmacogenomics J, 2004. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers. Papers, record 14647405. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14647405
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytochrome P-450 Enzyme System | Major topic |
| Nifedipine | Major topic |
| Adult | |
| Analysis of Variance | |
| Area Under Curve | |
| Cytochrome P-450 CYP3A | |
| Female | |
| Genotype | |
| Humans | |
| Male |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11502729 | Genetic polymorphism of cytochrome P450 3A5 in Chinese. | Drug Metab Dispos | 2001 | https://conductscience.org/library/papers/11502729 | PubMed |
| 2 | 12042671 | Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population. | Pharmacogenetics | 2002 | https://conductscience.org/library/papers/12042671 | PubMed |
| 3 | 8561495 | Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. | Arch Biochem Biophys | 1996 | https://conductscience.org/library/papers/8561495 | PubMed |
| 4 | 10213372 | Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. | Pharm Res | 1999 | https://conductscience.org/library/papers/10213372 | PubMed |
| 5 | 9328287 | Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase. | Arch Biochem Biophys | 1997 | https://conductscience.org/library/papers/9328287 | PubMed |
| 6 | 11231118 | Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport. | Eur J Pharm Sci | 2001 | https://conductscience.org/library/papers/11231118 | PubMed |
| 7 | 11740341 | The genetic determinants of the CYP3A5 polymorphism. | Pharmacogenetics | 2001 | https://conductscience.org/library/papers/11740341 | PubMed |
| 8 | 8035341 | Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. | J Pharmacol Exp Ther | 1994 | https://conductscience.org/library/papers/8035341 | PubMed |
| 9 | 12124305 | Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. | Drug Metab Dispos | 2002 | https://conductscience.org/library/papers/12124305 | PubMed |
| 10 | 10511065 | Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4. | Clin Pharmacol Ther | 1999 | https://conductscience.org/library/papers/10511065 | PubMed |
| 11 | 3203042 | The pharmacokinetics of oral nifedipine--a population study. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3203042 | PubMed |
| 12 | 6746815 | Liquid chromatographic determination of nifedipine in plasma and of its main metabolite in urine. | J Chromatogr | 1984 | https://conductscience.org/library/papers/6746815 | PubMed |
| 13 | 12065767 | Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. | Mol Pharmacol | 2002 | https://conductscience.org/library/papers/12065767 | PubMed |
| 14 | 12228187 | Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. | Drug Metab Dispos | 2002 | https://conductscience.org/library/papers/12228187 | PubMed |
| 15 | 7826796 | Midazolam is metabolized by at least three different cytochrome P450 enzymes. | Br J Anaesth | 1994 | https://conductscience.org/library/papers/7826796 | PubMed |
| 16 | 10898107 | Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. | Pharmacogenetics | 2000 | https://conductscience.org/library/papers/10898107 | PubMed |
| 17 | 12413960 | Identification of the novel splicing variants for the hPXR in human livers. | Biochem Biophys Res Commun | 2002 | https://conductscience.org/library/papers/12413960 | PubMed |
| 18 | 12756208 | Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. | Drug Metab Dispos | 2003 | https://conductscience.org/library/papers/12756208 | PubMed |
| 19 | 9923580 | Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects. | Eur J Clin Pharmacol | 1998 | https://conductscience.org/library/papers/9923580 | PubMed |
| 20 | 2732228 | Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2732228 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29947950 | Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans. | Eur J Clin Pharmacol | 2018 | https://conductscience.org/library/papers/29947950 | PubMed |
| 23835882 | A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine Pharmacokinetics. | CPT Pharmacometrics Syst Pharmacol | 2012 | https://conductscience.org/library/papers/23835882 | PubMed |
| 22875663 | Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic. | Am J Perinatol | 2013 | https://conductscience.org/library/papers/22875663 | PubMed |
| 21836356 | Inferences from targeting CYP450 modulation to decrease the risk of induced cataract in the experimental model? | Indian J Ophthalmol | 2011 | https://conductscience.org/library/papers/21836356 | PubMed |
| 19907160 | CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease. | Am J Nephrol | 2010 | https://conductscience.org/library/papers/19907160 | PubMed |
| 19205682 | Effects of CYP3A5, MDR1 and CACNA1C polymorphisms on the oral disposition and response of nimodipine in a Chinese cohort. | Eur J Clin Pharmacol | 2009 | https://conductscience.org/library/papers/19205682 | PubMed |
| 19076156 | Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa. | Br J Clin Pharmacol | 2009 | https://conductscience.org/library/papers/19076156 | PubMed |
| 18385991 | Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18385991 | PubMed |
| 18214455 | Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18214455 | PubMed |
| 16638735 | Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition. | J Clin Pharmacol | 2006 | https://conductscience.org/library/papers/16638735 | PubMed |
| 16430309 | Significance of the minor cytochrome P450 3A isoforms. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16430309 | PubMed |
| 15483658 | Importance of patient selection when determining the significance of the CYP3A5 polymorphism in clinical trials. | Pharmacogenomics J | 2004 | https://conductscience.org/library/papers/15483658 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| CYP3A5 | 1577 | PubTator's text mining | https://conductscience.org/library/genes/1577 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14647405
GET https://conductscience.org/api/papers/v1/14647405/references?page=2